KRAS and oral cavity squamous cell carcinoma: Wang et al. [7] reported that the rs712 polymorphism in the KRAS 3’ UTR was associated with a reduced risk for oral squamous cell carcinoma, while rs1137282 in KRAS exon 6 was not [35].